Wednesday, October 28, 2026Eastern Time · Updated through the dayRSS

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Lilly's retatrutide outshines Ozempic on weight loss, blood sugar control in trial

MH

By Maren Holt · Senior Reporter, GLP-1

Oct 28 12:38 ETSource: Reuters

From the source

Lilly's retatrutide outshines Ozempic on weight loss, blood sugar control in trial

Read at reuters.com

Source URL https://www.reuters.com/legal/litigation/lillys-next-gen-drug-outshines-ozempic-weight-loss-blood-sugar-control-trial-2026-10-28/

Prescribed peptides from $99/moSee all →